Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): May 3, 2004

 


 

NANOGEN, INC.

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware   000-23541   33-0489621

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

10398 Pacific Center Court, San Diego, California   92121
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (858) 410-4600

 



Item 12. Results of Operations and Financial Condition.

 

On May 3, 2004, Nanogen, Inc. issued a press release reporting certain financial results for the quarter ended March 31, 2004. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated into this Form 8-K by reference.

 

The information contained in this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NANOGEN, INC.

Dated: May 3, 2004

 

By:

 

/s/ David Ludvigson


       

David Ludvigson,

       

Executive Vice President

       

Chief Financial Officer and Treasurer


EXHIBIT INDEX

 

Exhibit

Number


 

Description of Document


99.1   Press Release of Nanogen, Inc., dated May 3, 2004.